The PRTN3 gene gives instructions for a protein in certain white blood cells that helps break down germs and damaged tissue during inflammation. If this system is not balanced, or if the immune system wrongly targets this protein, blood vessel inflammation can develop, including ANCA associated vasculitis, where antibodies attack parts of white blood cells. This gene helps your body control part of the early immune response. Some variants in the PRTN3 gene may influence risk, but they do not by themselves diagnose disease.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the working parts of cells. Others mostly help determine when certain processes happen, where they happen, and how strongly they take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more information in the LearnHub.
Overview
PRTN3Gene function
What if the gene works
The PRTN3 gene helps make proteinase 3, an enzyme in neutrophils, a type of white blood cell. It helps break down proteins in these cells and supports the body’s response to germs and inflammation.
Risk
What if the gene does not work
Milder to more severe variants in the PRTN3 gene can reduce or alter proteinase 3 activity in neutrophils, the white blood cells that help fight infection. This may change protein breakdown and inflammatory signaling inside these cells.
Treatment
What does that mean for your treatment
No treatment or drug choice approach that depends on pathogenic variants in the PRTN3 gene is currently established. In research, the PRTN3 gene is mainly studied as a disease marker and immune target in ANCA associated vasculitis, rather than a guide to therapy.
Conditions associated with PRTN3
Gene function
What if the gene works
Your body uses the PRTN3 gene mainly in neutrophils, a type of white blood cell that responds early to infection. It gives these cells instructions for making a protein cutting enzyme stored until needed. Knowing what the PRTN3 gene does in the body helps explain how your innate immune system handles everyday germ exposure.
In neutrophils, the PRTN3 gene provides instructions for an enzyme that cuts proteins inside swallowed germs. This supports the body’s fast first line defense against infection.
Its protein is packed into neutrophil granules, small storage sacs filled with defense tools. When needed, these sacs release their contents at sites of infection or tissue injury.
Proteinase 3 also trims certain human proteins. This helps fine tune local immune signals and supports coordinated early inflammation.
By breaking down selected proteins outside cells, it helps neutrophils move through tissue to reach areas that need immune defense. This is part of a normal early response to germs or injury.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PRTN3 gene can change how much protein is made, how well it folds, and how active it is inside certain white blood cells. When people look at how PRTN3 gene variants affect protein function, the main effects are usually reduced stability, altered enzyme activity, or less efficient storage and release from cell granules. Some variants have mild effects, while more severe variants can leave little or no working protein, which may shift the overall functional impact.
How variants are linked to conditions
Variants in the PRTN3 gene have been linked to a higher chance of PR3-ANCA positive ANCA-associated vasculitis, especially granulomatosis with polyangiitis. Research on PRTN3 gene variants linked to granulomatosis with polyangiitis shows a risk association rather than a certain outcome. Many people with a PRTN3 gene change never develop this condition.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect the natural variation seen among people. In many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences contribute. There are cases, though, where one well-characterized variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PRTN3 gene itself. For the related type of blood vessel inflammation, risk can also be shaped by other genes and outside factors such as immune triggers and some workplace dust exposures.
Inheritance of PRTN3 variants
There is not yet a broadly confirmed Mendelian pattern for disease causing PRTN3 gene changes, so the inheritance of PRTN3 gene variants is not described as a clear autosomal dominant or autosomal recessive condition. Some variants in the PRTN3 gene may influence susceptibility to certain immune related conditions, but they do not follow a single well established family pattern. The PRTN3 gene is located on chromosome 19, which is an autosome, so you inherit one copy from each parent.
What does my PRTN3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for the PRTN3 gene. If you have a PRTN3 result and want to understand what it could mean for your relatives, a doctor or genetic counselor can explain it in the context of your exact result and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PRTN3 variants usually uses a blood or saliva sample. A lab reads the DNA sequence of the PRTN3 gene to look for variants and may compare the result with known evidence to classify whether a finding is linked to disease or remains uncertain.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order genetic testing just for the PRTN3 gene. Decisions about testing are usually made with a doctor or genetic counselor based on your symptoms, family history, and whether a broader gene panel fits the situation.
A genetic result is only one part of your health story
Genetic results can be very informative, but how much they reveal varies depending on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have little effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape the way a person responds to medication. It focuses on links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can help guide more informed and individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the PRTN3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so general concerns about symptoms, treatment, or side effects are best discussed with your doctor.
History
The PRTN3 gene entered medical research through studies of a neutrophil protein later called proteinase 3. In the 1980s, doctors recognized a new antibody pattern in some forms of vasculitis, and this led researchers to identify proteinase 3 as one of the main targets. Building on this early work, scientists linked the PRTN3 gene more clearly to granulomatosis with polyangiitis, a condition once called Wegener granulomatosis. Through the 1990s and 2000s, the gene became part of a broader shift toward blood tests that could help classify inflammatory blood vessel conditions. Over time, descriptions became more precise, and the PRTN3 gene gained a lasting place in the history of autoimmune disease research.